# Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension

Study · id `cardio:ct-nct05049096` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05049096](<https://clinicaltrials.gov/study/NCT05049096>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05049096

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 103 participants.

## Technical summary

Registry record NCT05049096. Randomized; triple masking; primary purpose treatment. Start 2021-11-01 (actual); primary completion 2023-11-20 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 103 participants (enrolled count; ClinicalTrials.gov record NCT05049096, source copy `cardio:ctgov-nct05049096-2023-12-07`, retrieved 2026-10-26)
- Started: 2021-11-01 (actual) (ClinicalTrials.gov record NCT05049096, source copy `cardio:ctgov-nct05049096-2023-12-07`, retrieved 2026-10-26)
- Primary completion: 2023-11-20 (actual) (ClinicalTrials.gov record NCT05049096, source copy `cardio:ctgov-nct05049096-2023-12-07`, retrieved 2026-10-26)
- Completion: 2023-11-20 (actual) (ClinicalTrials.gov record NCT05049096, source copy `cardio:ctgov-nct05049096-2023-12-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05049096, source copy `cardio:ctgov-nct05049096-2023-12-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05049096-2023-12-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Focused Power Ultrasound Mediated Inferior Perirenal Adipose Tissue Modification Therapy for Essential Hypertension
- Acronym: PARADISE-HTN
- Condition: Hypertension
- Condition: Blood Pressure
- Condition: Cardiovascular Diseases
- Intervention (Device): focused power ultrasound mediate inferior perirenal adipose tussue modification
- Intervention (Device): sham-control group
- Lead sponsor: The First Affiliated Hospital with Nanjing Medical University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry lists this organization as the lead sponsor: The First Affiliated Hospital with Nanjing Medical University (`cardio:org-the-first-affiliated-hospital-with-nanjing-medical-898271`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Perirenal fat as a potential marker and therapeutic target for metabolic syndrome: insights from a multicenter randomized controlled trial (`cardio:pubmed-40487756`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d7faeffd1c1ee0a74a779f1156a1c416ed8bdfe07bf0173d2bb2fbeb26501f37
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
